BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 9057658)

  • 1. DNA mismatch repair in HIV-Associated Lymphoma: Lost in Translation?
    Jiang Y; Chen S; Xia M; Xu X; Peng J; Cai S
    J Infect; 2024 Mar; 88(3):106112. PubMed ID: 38290665
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymic cancer in lynch syndrome: an unusual association.
    Pandey D; Shepro DS
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32273268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-associated myelodysplastic syndrome with monosomy 7 arising in a Muir-Torre Syndrome patient carrying
    Ullman D; Baumgartner E; Wnukowski N; Koenig G; Mikhail FM; Pavlidakey P; Peker D
    Mol Clin Oncol; 2018 Feb; 8(2):306-309. PubMed ID: 29435294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective tumor cell death induced by irradiated riboflavin through recognizing DNA G-T mismatch.
    Yuan Y; Zhao Y; Chen L; Wu J; Chen G; Li S; Zou J; Chen R; Wang J; Jiang F; Tang Z
    Nucleic Acids Res; 2017 Sep; 45(15):8676-8683. PubMed ID: 28911109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.
    Springuel L; Losdyck E; Saussoy P; Turcq B; Mahon FX; Knoops L; Renauld JC
    Cell Mol Life Sci; 2016 Dec; 73(24):4739-4748. PubMed ID: 27436342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracolonic manifestations of lynch syndrome.
    Bansidhar BJ
    Clin Colon Rectal Surg; 2012 Jun; 25(2):103-10. PubMed ID: 23730225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
    Horton TM; Jenkins G; Pati D; Zhang L; Dolan ME; Ribes-Zamora A; Bertuch AA; Blaney SM; Delaney SL; Hegde M; Berg SL
    Mol Cancer Ther; 2009 Aug; 8(8):2232-42. PubMed ID: 19671751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
    Horton TM; Thompson PA; Berg SL; Adamson PC; Ingle AM; Dolan ME; Delaney SM; Hedge M; Weiss HL; Wu MF; Blaney SM;
    J Clin Oncol; 2007 Nov; 25(31):4922-8. PubMed ID: 17971589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
    Wu X; Platt JL; Cascalho M
    Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frameshift mutations of the hMSH6 gene in human leukemia cell lines.
    Hosoya N; Hangaishi A; Ogawa S; Miyagawa K; Mitani K; Yazaki Y; Hirai H
    Jpn J Cancer Res; 1998 Jan; 89(1):33-9. PubMed ID: 9510473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.
    Drexler HG; Quentmeier H
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations and loss of expression of a mismatch repair gene, hMLH1, in leukemia and lymphoma cell lines.
    Hangaishi A; Ogawa S; Mitani K; Hosoya N; Chiba S; Yazaki Y; Hirai H
    Blood; 1997 Mar; 89(5):1740-7. PubMed ID: 9057658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias.
    Auner HW; Olipitz W; Hoefler G; Bodner C; Konrad D; Crevenna R; Linkesch W; Sill H
    Br J Haematol; 1999 Sep; 106(3):706-8. PubMed ID: 10468860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
    Wheeler JM; Beck NE; Kim HC; Tomlinson IP; Mortensen NJ; Bodmer WF
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10296-301. PubMed ID: 10468602
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.